Royce & Associates’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-492,505
| Closed | -$7.31M | – | 803 |
|
|
2025
Q4 | $7.31M | Buy |
492,505
+53,000
| +12% | +$749K | 0.07% | 395 |
|
|
2025
Q3 | $5.64M | Buy |
439,505
+39,300
| +10% | +$524K | 0.06% | 443 |
|
|
2025
Q2 | $6.08M | Sell |
400,205
-1,150
| -0.3% | -$17.9K | 0.06% | 422 |
|
|
2025
Q1 | $6.7M | Buy |
401,355
+28,190
| +8% | +$519K | 0.07% | 386 |
|
|
2024
Q4 | $7.03M | Sell |
373,165
-270,264
| -42% | -$5.21M | 0.07% | 414 |
|
|
2024
Q3 | $12.1M | Buy |
643,429
+3,545
| +0.6% | +$67.9K | 0.11% | 267 |
|
|
2024
Q2 | $12.1M | Buy |
639,884
+7,266
| +1% | +$124K | 0.11% | 262 |
|
|
2024
Q1 | $10.3M | Sell |
632,618
-32,279
| -5% | -$473K | 0.09% | 308 |
|
|
2023
Q4 | $8.42M | Buy |
664,897
+58,278
| +10% | +$735K | 0.08% | 363 |
|
|
2023
Q3 | $8.26M | Sell |
606,619
-14,751
| -2% | -$228K | 0.08% | 343 |
|
|
2023
Q2 | $10.7M | Sell |
621,370
-140,128
| -18% | -$2.17M | 0.1% | 295 |
|
|
2023
Q1 | $10.6M | Sell |
761,498
-6,125
| -0.8% | -$90.2K | 0.11% | 288 |
|
|
2022
Q4 | $10.3M | Sell |
767,623
-17,446
| -2% | -$226K | 0.11% | 285 |
|
|
2022
Q3 | $9.35M | Sell |
785,069
-50,450
| -6% | -$717K | 0.11% | 283 |
|
|
2022
Q2 | $10.6M | Buy |
835,519
+5,224
| +0.6% | +$67.1K | 0.11% | 270 |
|
|
2022
Q1 | $10.7M | Buy |
830,295
+234,864
| +39% | +$3.1M | 0.09% | 338 |
|
|
2021
Q4 | $9.43M | Sell |
595,431
-78,835
| -12% | -$1.35M | 0.07% | 408 |
|
|
2021
Q3 | $13.1M | Sell |
674,266
-262,340
| -28% | -$5.21M | 0.1% | 335 |
|
|
2021
Q2 | $21.3M | Sell |
936,606
-334,080
| -26% | -$6.93M | 0.15% | 226 |
|
|
2021
Q1 | $23.3M | Buy |
1,270,686
+430,406
| +51% | +$7.06M | 0.16% | 206 |
|
|
2020
Q4 | $12.5M | Sell |
840,280
-17,632
| -2% | -$230K | 0.1% | 312 |
|
|
2020
Q3 | $9.62M | Buy |
857,912
+19,303
| +2% | +$190K | 0.1% | 291 |
|
|
2020
Q2 | $6.66M | Buy |
838,609
+149,465
| +22% | +$1.24M | 0.07% | 386 |
|
|
2020
Q1 | $5.57M | Sell |
689,144
-105,792
| -13% | -$1.26M | 0.08% | 345 |
|
|
2019
Q4 | $10M | Sell |
794,936
-48,256
| -6% | -$520K | 0.09% | 321 |
|
|
2019
Q3 | $7.53M | Buy |
843,192
+32,907
| +4% | +$288K | 0.07% | 377 |
|
|
2019
Q2 | $6.93M | Buy |
810,285
+46,214
| +6% | +$365K | 0.06% | 412 |
|
|
2019
Q1 | $5.8M | Buy |
764,071
+160,544
| +27% | +$1.29M | 0.05% | 474 |
|
|
2018
Q4 | $4.99M | Buy |
603,527
+462,573
| +328% | +$4.43M | 0.04% | 506 |
|
|
2018
Q3 | $1.4M | Sell |
140,954
-12,250
| -8% | -$127K | 0.01% | 878 |
|
|
2018
Q2 | $1.5M | Sell |
153,204
-64,960
| -30% | -$638K | 0.01% | 891 |
|
|
2018
Q1 | $2.03M | Sell |
218,164
-43,987
| -17% | -$419K | 0.01% | 853 |
|
|
2017
Q4 | $2.49M | Buy |
262,151
+32,851
| +14% | +$314K | 0.02% | 795 |
|
|
2017
Q3 | $2.37M | Sell |
229,300
-104,864
| -31% | -$968K | 0.02% | 784 |
|
|
2017
Q2 | $2.76M | Sell |
334,164
-79,353
| -19% | -$596K | 0.02% | 763 |
|
|
2017
Q1 | $2.97M | Buy |
413,517
+135,117
| +49% | +$979K | 0.02% | 742 |
|
|
2016
Q4 | $1.99M | Sell |
278,400
-46,400
| -14% | -$323K | 0.01% | 826 |
|
|
2016
Q3 | $2.36M | Sell |
324,800
-46,400
| -13% | -$295K | 0.02% | 755 |
|
|
2016
Q2 | $2.17M | Buy |
371,200
+4,640
| +1% | +$30.7K | 0.01% | 793 |
|
|
2016
Q1 | $2.33M | Buy |
366,560
+13,920
| +4% | +$74.7K | 0.01% | 805 |
|
|
2015
Q4 | $2.26M | Buy |
352,640
+48,256
| +16% | +$302K | 0.01% | 830 |
|
|
2015
Q3 | $1.77M | Buy |
304,384
+49,184
| +19% | +$365K | 0.01% | 888 |
|
|
2015
Q2 | $2.23M | Sell |
255,200
-116,000
| -31% | -$974K | 0.01% | 914 |
|
|
2015
Q1 | $2.97M | Sell |
371,200
-553,300
| -60% | -$4.13M | 0.01% | 860 |
|
|
2014
Q4 | $7.17M | Sell |
924,500
-357,280
| -28% | -$2.61M | 0.02% | 701 |
|
|
2014
Q3 | $8.31M | Sell |
1,281,780
-682,080
| -35% | -$5.27M | 0.03% | 669 |
|
|
2014
Q2 | $16.5M | Sell |
1,963,860
-454,720
| -19% | -$3.53M | 0.05% | 466 |
|
|
2014
Q1 | $16.2M | Sell |
2,418,580
-185,600
| -7% | -$1.13M | 0.05% | 490 |
|
|
2013
Q4 | $16.3M | Sell |
2,604,180
-59,763
| -2% | -$292K | 0.05% | 477 |
|
|
2013
Q3 | $11.6M | Buy |
2,663,943
+154,976
| +6% | +$708K | 0.03% | 598 |
|
|
2013
Q2 | $11.1M | Buy |
+2,508,967
| New | +$11.1M | 0.03% | 586 |
|
Other funds holding SEM
GCL
Royce & Associates's SEM Position: Q1 2026 in Review
Royce & Associates sold out of Select Medical (SEM) in Q1 2026, closing a stake of 492,505 shares — an estimated $7.31M sold.
Royce & Associates first reported a position in SEM in Q2 2013 and held it in 51 quarters. The position peaked at $23.3M in Q1 2021. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.
- Royce & Associates reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
- Royce & Associates sold 492,505 Select Medical shares in Q1 2026, an estimated $7.31M.
- Royce & Associates first reported a position in Select Medical in Q2 2013 and held it in 51 quarters.
- Royce & Associates's Select Medical position peaked at $23.3M in Q1 2021.
- 278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.
Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.